IXICO’s New Biotech Contracts Help Drive Growth
Executive Summary
Expanding its client focus and getting smaller biotech companies on board as clients has enabled brain health imaging company IXICO to gain commercial traction this fiscal year. Subsequently, the AIM-listed firm is expecting to turn out financial results at the end of September that will exceed market expectations.